BML-278, CAS [[120533-76-8]]

Artikelnummer: MCE-HY-W025074
Artikelname: BML-278, CAS [[120533-76-8]]
Artikelnummer: MCE-HY-W025074
Hersteller Artikelnummer: HY-W025074
Alternativnummer: MCE-HY-W025074-50MG,MCE-HY-W025074-10MMX1ML,MCE-HY-W025074-5MG,MCE-HY-W025074-25MG,MCE-HY-W025074-10MG
Hersteller: MedchemExpress
Kategorie: Biochemikalien
BML-278 is a SIRT1 activator (EC150: 1 µM). BML-278 increases H3K9 methylation and inhibits H3K9 acetylation in both the paternal and maternal pronucleus. BML-278 improves early embryonic development. BML-278 arrests the cell cycle at the G1/S phase, and reduces senescence in primary human mesenchymal cells. BML-278 reduces tubulin acetylation in U937 cells. BML-278 also increases mitochondrial density in murine C2C12 myoblasts[1][2].
Molekulargewicht: 391.46
Reinheit: 98.49
CAS Nummer: [120533-76-8]
Formel: C24H25NO4
Target-Kategorie: Histone Methyltransferase,Sirtuin
Anwendungsbeschreibung: MCE Product type: Reference compound